Abstract |
An original synthesis of the acetogenin muricadienin, the bioprecursor of solamin, has been developed. The key step in the five-step 41% overall yield synthesis is the catalytic cross-cyclomagnesiation reaction of functionally substituted 1,2-dienes with EtMgBr in the presence of Cp2TiCl2 and magnesium metal. It has been demonstrated for the first time that muricadienin exhibits a moderate in vitro inhibitory activity against topoisomerases I and IIα, key cell cycle enzymes. Using flow cytometry, muricadienin was shown to have high cytotoxicity toward the HEK293 kidney cancer cells (IC50 0.39 μM).
|
Authors | Usein M Dzhemilev, Vladimir A D'yakonov, Regina A Tuktarova, Lilya U Dzhemileva, Svetlana R Ishmukhametova, Milyausha M Yunusbaeva, Armin de Meijere |
Journal | Journal of natural products
(J Nat Prod)
Vol. 79
Issue 8
Pg. 2039-44
(08 26 2016)
ISSN: 1520-6025 [Electronic] United States |
PMID | 27533261
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Acetogenins
- Antineoplastic Agents
- Topoisomerase I Inhibitors
- muricadienin
- Benzethonium
- DNA Topoisomerases, Type I
- TOP1 protein, human
- DNA Topoisomerases, Type II
|
Topics |
- Acetogenins
(chemical synthesis, chemistry, pharmacology)
- Antineoplastic Agents
(chemical synthesis, chemistry, pharmacology)
- Benzethonium
(chemistry)
- DNA Topoisomerases, Type I
(metabolism)
- DNA Topoisomerases, Type II
(metabolism)
- Drug Screening Assays, Antitumor
- HEK293 Cells
- Humans
- Molecular Structure
- Topoisomerase I Inhibitors
(pharmacology)
|